These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The human clinical phenotypes of altered CHRNA7 copy number. Gillentine MA; Schaaf CP Biochem Pharmacol; 2015 Oct; 97(4):352-362. PubMed ID: 26095975 [TBL] [Abstract][Full Text] [Related]
4. Copy number variations in healthy subjects. Case study: iPSC line CSSi005-A (3544) production from an individual with variation in 15q13.3 chromosome duplicating gene CHRNA7. Turco EM; Vinci E; Altieri F; Ferrari D; Torres B; Goldoni M; Lamorte G; Tata AM; Mazzoccoli G; Postorivo D; Della Monica M; Bernardini L; Vescovi AL; Rosati J Stem Cell Res; 2018 Oct; 32():73-77. PubMed ID: 30218896 [TBL] [Abstract][Full Text] [Related]
5. CHRNA7 triplication associated with cognitive impairment and neuropsychiatric phenotypes in a three-generation pedigree. Soler-Alfonso C; Carvalho CM; Ge J; Roney EK; Bader PI; Kolodziejska KE; Miller RM; Lupski JR; Stankiewicz P; Cheung SW; Bi W; Schaaf CP Eur J Hum Genet; 2014 Sep; 22(9):1071-6. PubMed ID: 24424125 [TBL] [Abstract][Full Text] [Related]
6. An acetylcholine alpha7 positive allosteric modulator rescues a schizophrenia-associated brain endophenotype in the 15q13.3 microdeletion, encompassing CHRNA7. Gass N; Weber-Fahr W; Sartorius A; Becker R; Didriksen M; Stensbøl TB; Bastlund JF; Meyer-Lindenberg A; Schwarz AJ Eur Neuropsychopharmacol; 2016 Jul; 26(7):1150-60. PubMed ID: 27061851 [TBL] [Abstract][Full Text] [Related]
7. Identification of single gene deletions at 15q13.3: further evidence that CHRNA7 causes the 15q13.3 microdeletion syndrome phenotype. Hoppman-Chaney N; Wain K; Seger PR; Superneau DW; Hodge JC Clin Genet; 2013 Apr; 83(4):345-51. PubMed ID: 22775350 [TBL] [Abstract][Full Text] [Related]
8. The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications. Gillentine MA; Berry LN; Goin-Kochel RP; Ali MA; Ge J; Guffey D; Rosenfeld JA; Hannig V; Bader P; Proud M; Shinawi M; Graham BH; Lin A; Lalani SR; Reynolds J; Chen M; Grebe T; Minard CG; Stankiewicz P; Beaudet AL; Schaaf CP J Autism Dev Disord; 2017 Mar; 47(3):549-562. PubMed ID: 27853923 [TBL] [Abstract][Full Text] [Related]
9. Mosaic 15q13.3 deletion including CHRNA7 gene in monozygotic twins. Popovici C; Busa T; Missirian C; Milh M; Moncla A; Philip N Eur J Med Genet; 2013 May; 56(5):274-7. PubMed ID: 23454271 [TBL] [Abstract][Full Text] [Related]
10. 15q13.3 duplication in two patients with childhood-onset schizophrenia. Zhou D; Gochman P; Broadnax DD; Rapoport JL; Ahn K Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):777-83. PubMed ID: 26968334 [TBL] [Abstract][Full Text] [Related]
11. Duplication Versus Deletion Through the Lens of 15q13.3: Clinical and Research Implications of Studying Copy Number Variants Associated with Neuropsychiatric Disorders in Induced Pluripotent Stem Cell-Derived Neurons. Antony I; Narasimhan M; Shen R; Prakasam R; Kaushik K; Chapman G; Kroll KL Stem Cell Rev Rep; 2023 Apr; 19(3):639-650. PubMed ID: 36370261 [TBL] [Abstract][Full Text] [Related]
12. A de novo nonsense mutation in ZBTB18 plus a de novo 15q13.3 microdeletion in a 6-year-old female. Ehmke N; Karge S; Buchmann J; Korinth D; Horn D; Reis O; Häßler F Am J Med Genet A; 2017 May; 173(5):1251-1256. PubMed ID: 28345786 [TBL] [Abstract][Full Text] [Related]
13. A small homozygous microdeletion of 15q13.3 including the CHRNA7 gene in a girl with a spectrum of severe neurodevelopmental features. Liao J; DeWard SJ; Madan-Khetarpal S; Surti U; Hu J Am J Med Genet A; 2011 Nov; 155A(11):2795-800. PubMed ID: 21990074 [TBL] [Abstract][Full Text] [Related]
14. The Phenotypic Spectrum of 15q13.3 Region Duplications: Report of 5 Patients. Budisteanu M; Papuc SM; Streata I; Cucu M; Pirvu A; Serban-Sosoi S; Erbescu A; Andrei E; Iliescu C; Ioana D; Severin E; Ioana M; Arghir A Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356041 [TBL] [Abstract][Full Text] [Related]
15. Chromosome 15q13.3 microduplications are associated with treatment refractory major depressive disorder. McClain L; Segreti AM; Nau S; Shaw P; Finegold DN; Pan LA; Peters DG Genes Brain Behav; 2020 Jun; 19(5):e12628. PubMed ID: 31828948 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome. Le Pichon JB; Yu S; Kibiryeva N; Graf WD; Bittel DC Eur J Hum Genet; 2013 Oct; 21(10):1093-9. PubMed ID: 23361223 [TBL] [Abstract][Full Text] [Related]
17. The 15q13.3 deletion syndrome: Deficient α(7)-containing nicotinic acetylcholine receptor-mediated neurotransmission in the pathogenesis of neurodevelopmental disorders. Deutsch SI; Burket JA; Benson AD; Urbano MR Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():109-17. PubMed ID: 26257138 [TBL] [Abstract][Full Text] [Related]
18. Targeted therapy with galantamine in a pediatric patient with 15q13.3 deletion syndrome. Casas-Alba D; Nolasco GA; Díez-Juan M; Mezzatesta M; Balañá G; Fons C Am J Med Genet A; 2021 Dec; 185(12):3897-3899. PubMed ID: 34272916 [No Abstract] [Full Text] [Related]
19. CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents. Gillentine MA; White JJ; Grochowski CM; Lupski JR; Schaaf CP; Calarge CA J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):908-915. PubMed ID: 28817303 [TBL] [Abstract][Full Text] [Related]
20. Further delineation of eye manifestations in homozygous 15q13.3 microdeletions including TRPM1: a differential diagnosis of ceroid lipofuscinosis. Masurel-Paulet A; Drumare I; Holder M; Cuisset JM; Vallée L; Defoort S; Bourgois B; Pernes P; Cuvellier JC; Huet F; Chehadeh SE; Thevenon J; Callier P; Thauvin C; Faivre L; Andrieux J Am J Med Genet A; 2014 Jun; 164A(6):1537-44. PubMed ID: 24668847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]